US5324520A
(en)
*
|
1988-12-19 |
1994-06-28 |
Vipont Pharmaceutical, Inc. |
Intragingival delivery systems for treatment of periodontal disease
|
FR2649321A1
(fr)
*
|
1989-07-07 |
1991-01-11 |
Inst Nat Sante Rech Med |
Compositions a base de derives nucleotidiques, leurs procedes de preparation, et leurs utilisations notamment en tant que compositions pharmaceutiques
|
US5439688A
(en)
*
|
1989-07-28 |
1995-08-08 |
Debio Recherche Pharmaceutique S.A. |
Process for preparing a pharmaceutical composition
|
US5268178A
(en)
*
|
1989-09-25 |
1993-12-07 |
The Board Of Regents, The University Of Texas System |
Biodegradable antibiotic implants and methods of their use in treating and preventing infections
|
FR2654337B1
(fr)
*
|
1989-11-15 |
1994-08-05 |
Roussel Uclaf |
Nouvelles microspheres injectables biodegradables procede de preparation et suspensions injectables les renfermant.
|
EP0438929B1
(de)
*
|
1990-01-22 |
1993-09-29 |
Eurogentec S.A. |
Mittel auf Somatotropinbasis zur Steuerung der Meereswasseradaptation von Zuchtlachsen
|
US5478564A
(en)
*
|
1990-02-22 |
1995-12-26 |
Teva Pharmaceutical Industries, Ltd. |
Preparation of microparticles for controlled release of water-soluble substances
|
FR2659554B1
(fr)
*
|
1990-03-16 |
1994-09-30 |
Oreal |
Composition pour le traitement cosmetique et/ou pharmaceutique des couches superieures de l'epiderme par application topique sur la peau et procede de preparation correspondant.
|
EP0489743A1
(de)
*
|
1990-07-03 |
1992-06-17 |
Vipont Pharmaceutical, Inc. |
Intragingivale vorrichtung zur verabreichung von wirkstoffen zur behandlung paradontaler krankheiten
|
CA2046830C
(en)
*
|
1990-07-19 |
1999-12-14 |
Patrick P. Deluca |
Drug delivery system involving inter-action between protein or polypeptide and hydrophobic biodegradable polymer
|
US5541155A
(en)
*
|
1994-04-22 |
1996-07-30 |
Emisphere Technologies, Inc. |
Acids and acid salts and their use in delivery systems
|
US5447728A
(en)
*
|
1992-06-15 |
1995-09-05 |
Emisphere Technologies, Inc. |
Desferrioxamine oral delivery system
|
US5714167A
(en)
|
1992-06-15 |
1998-02-03 |
Emisphere Technologies, Inc. |
Active agent transport systems
|
US6221367B1
(en)
|
1992-06-15 |
2001-04-24 |
Emisphere Technologies, Inc. |
Active agent transport systems
|
US5693338A
(en)
*
|
1994-09-29 |
1997-12-02 |
Emisphere Technologies, Inc. |
Diketopiperazine-based delivery systems
|
US6331318B1
(en)
|
1994-09-30 |
2001-12-18 |
Emisphere Technologies Inc. |
Carbon-substituted diketopiperazine delivery systems
|
US5629020A
(en)
|
1994-04-22 |
1997-05-13 |
Emisphere Technologies, Inc. |
Modified amino acids for drug delivery
|
US6099856A
(en)
|
1992-06-15 |
2000-08-08 |
Emisphere Technologies, Inc. |
Active agent transport systems
|
US5443841A
(en)
*
|
1992-06-15 |
1995-08-22 |
Emisphere Technologies, Inc. |
Proteinoid microspheres and methods for preparation and use thereof
|
US5451410A
(en)
*
|
1993-04-22 |
1995-09-19 |
Emisphere Technologies, Inc. |
Modified amino acids for encapsulating active agents
|
WO1994023767A1
(en)
*
|
1993-04-22 |
1994-10-27 |
Emisphere Technologies, Inc. |
Oral drug delivery compositions and methods
|
US5578323A
(en)
*
|
1992-06-15 |
1996-11-26 |
Emisphere Technologies, Inc. |
Proteinoid carriers and methods for preparation and use thereof
|
US5238714A
(en)
*
|
1990-10-02 |
1993-08-24 |
Board Of Regents, The University Of Texas System |
Efficient microcapsule preparation and method of use
|
US5484584A
(en)
*
|
1990-10-02 |
1996-01-16 |
Board Of Regents, The University Of Texas System |
Therapeutic and diagnostic use of modified polymeric microcapsules
|
IT1247472B
(it)
|
1991-05-31 |
1994-12-17 |
Fidia Spa |
Processo per la preparazione di microsfere contenenti componenti biologicamente attivi.
|
ATE142460T1
(de)
*
|
1991-06-21 |
1996-09-15 |
Genetics Inst |
Osteogene proteine enthaltende arzneimittel
|
CH683149A5
(fr)
*
|
1991-07-22 |
1994-01-31 |
Debio Rech Pharma Sa |
Procédé pour la préparation de microsphères en matériau polymère biodégradable.
|
JPH0539381A
(ja)
*
|
1991-08-08 |
1993-02-19 |
Mitsui Toatsu Chem Inc |
生分解性ポリマー組成物
|
ES2034891B1
(es)
*
|
1991-08-08 |
1993-12-16 |
Cusi Lab |
Procedimiento de elaboracion en continuo de sistemas coloidales dispersos, en forma de nanocapsulas o nanoparticulas.
|
WO1993015722A1
(en)
*
|
1992-02-07 |
1993-08-19 |
Syntex (Usa) Inc. |
Controlled delivery of pharmaceuticals from preformed porous microparticles
|
US5912015A
(en)
|
1992-03-12 |
1999-06-15 |
Alkermes Controlled Therapeutics, Inc. |
Modulated release from biocompatible polymers
|
US5429822A
(en)
*
|
1992-03-13 |
1995-07-04 |
Cambridge Scientific, Inc. |
Biodegradable bursting release system
|
US5811127A
(en)
|
1992-06-15 |
1998-09-22 |
Emisphere Technologies, Inc. |
Desferrioxamine oral delivery system
|
US5792451A
(en)
|
1994-03-02 |
1998-08-11 |
Emisphere Technologies, Inc. |
Oral drug delivery compositions and methods
|
DE4223169C1
(de)
*
|
1992-07-10 |
1993-11-25 |
Ferring Arzneimittel Gmbh |
Verfahren zur Mikroverkapselung wasserlöslicher Wirkstoffe
|
JP2651320B2
(ja)
*
|
1992-07-16 |
1997-09-10 |
田辺製薬株式会社 |
徐放性マイクロスフェア製剤の製造方法
|
FR2693905B1
(fr)
*
|
1992-07-27 |
1994-09-02 |
Rhone Merieux |
Procédé de préparation de microsphères pour la libération prolongée de l'hormone LHRH et ses analogues, microsphères et formulations obtenues.
|
US5922340A
(en)
|
1992-09-10 |
1999-07-13 |
Children's Medical Center Corporation |
High load formulations and methods for providing prolonged local anesthesia
|
US5670173A
(en)
*
|
1992-09-14 |
1997-09-23 |
Mcgill University |
Biodegradable polymer membrane containing hemoglobin for blood substitute
|
EP0595030A3
(de)
*
|
1992-10-01 |
1995-06-07 |
Tanabe Seiyaku Co |
Mehrkern-Mikrosphären mit verzögerter Wirkstoffabgabe und Verfahren zu deren Herstellung.
|
WO1994009898A1
(de)
*
|
1992-10-26 |
1994-05-11 |
Schwarz Pharma Ag |
Verfahren zur herstellung von mikrokapseln
|
US5310742A
(en)
*
|
1992-11-30 |
1994-05-10 |
Elias Alan N |
Uses for thioureylenes
|
EP0674506B1
(de)
*
|
1992-12-02 |
2000-08-23 |
Alkermes Controlled Therapeutics, Inc. |
Wachstumhormon enthaltende mikrosphaeren mit kontrollierter freisetzung
|
US5401516A
(en)
*
|
1992-12-21 |
1995-03-28 |
Emisphere Technologies, Inc. |
Modified hydrolyzed vegetable protein microspheres and methods for preparation and use thereof
|
CA2151260A1
(en)
*
|
1993-02-23 |
1994-09-01 |
Pankaj B. Gala |
A process for the preparation of substantially alcohol free pharmaceutical compositions
|
PT686045E
(pt)
*
|
1993-02-23 |
2001-04-30 |
Genentech Inc |
Estabilizacao por excipientes de polipeptidos tratados com solventes organicos
|
US5981719A
(en)
|
1993-03-09 |
1999-11-09 |
Epic Therapeutics, Inc. |
Macromolecular microparticles and methods of production and use
|
US6090925A
(en)
|
1993-03-09 |
2000-07-18 |
Epic Therapeutics, Inc. |
Macromolecular microparticles and methods of production and use
|
US5643957A
(en)
|
1993-04-22 |
1997-07-01 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
ZA939608B
(en)
*
|
1993-04-22 |
1994-08-24 |
Emisphere Tech Inc |
Modified hydrolyzed vegetable protein microspheres and methods for preparation and use thereof.
|
US6461643B2
(en)
*
|
1993-04-22 |
2002-10-08 |
Emisphere Technologies, Inc. |
Oral drug delivery compositions and methods
|
US5709861A
(en)
*
|
1993-04-22 |
1998-01-20 |
Emisphere Technologies, Inc. |
Compositions for the delivery of antigens
|
US5958457A
(en)
|
1993-04-22 |
1999-09-28 |
Emisphere Technologies, Inc. |
Compositions for the delivery of antigens
|
GB9310781D0
(en)
*
|
1993-05-25 |
1993-07-14 |
Davis Stanley S |
Preparation of microparticles
|
US5603960A
(en)
*
|
1993-05-25 |
1997-02-18 |
O'hagan; Derek T. |
Preparation of microparticles and method of immunization
|
US5773025A
(en)
|
1993-09-09 |
1998-06-30 |
Edward Mendell Co., Inc. |
Sustained release heterodisperse hydrogel systems--amorphous drugs
|
US5455046A
(en)
*
|
1993-09-09 |
1995-10-03 |
Edward Mendell Co., Inc. |
Sustained release heterodisperse hydrogel systems for insoluble drugs
|
US6726930B1
(en)
*
|
1993-09-09 |
2004-04-27 |
Penwest Pharmaceuticals Co. |
Sustained release heterodisperse hydrogel systems for insoluble drugs
|
US6080429A
(en)
*
|
1993-10-25 |
2000-06-27 |
Genentech, Inc. |
Method for drying microspheres
|
US6913767B1
(en)
|
1993-10-25 |
2005-07-05 |
Genentech, Inc. |
Compositions for microencapsulation of antigens for use as vaccines
|
US5650173A
(en)
*
|
1993-11-19 |
1997-07-22 |
Alkermes Controlled Therapeutics Inc. Ii |
Preparation of biodegradable microparticles containing a biologically active agent
|
EP0804249A2
(de)
*
|
1994-03-15 |
1997-11-05 |
Brown University Research Foundation |
Polymeres system zur freisetzung von genen
|
IE940292A1
(en)
*
|
1994-04-06 |
1995-10-18 |
Elan Corp Plc |
Biodegradable microcapsules and method for their manufacture
|
US5626862A
(en)
|
1994-08-02 |
1997-05-06 |
Massachusetts Institute Of Technology |
Controlled local delivery of chemotherapeutic agents for treating solid tumors
|
US6001347A
(en)
|
1995-03-31 |
1999-12-14 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
US6090958A
(en)
|
1995-03-31 |
2000-07-18 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
US5989539A
(en)
|
1995-03-31 |
1999-11-23 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
US5866536A
(en)
|
1995-03-31 |
1999-02-02 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
US5650386A
(en)
*
|
1995-03-31 |
1997-07-22 |
Emisphere Technologies, Inc. |
Compositions for oral delivery of active agents
|
US5965121A
(en)
|
1995-03-31 |
1999-10-12 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
CN1151836C
(zh)
|
1995-03-31 |
2004-06-02 |
艾米斯菲尔技术有限公司 |
用作传送活性剂的化合物和组合物
|
US5820881A
(en)
*
|
1995-04-28 |
1998-10-13 |
Emisphere Technologies, Inc. |
Microspheres of diamide-dicarboxylic acids
|
US5824345A
(en)
*
|
1995-06-07 |
1998-10-20 |
Emisphere Technologies, Inc. |
Fragrances and flavorants
|
US5667806A
(en)
*
|
1995-06-07 |
1997-09-16 |
Emisphere Technologies, Inc. |
Spray drying method and apparatus
|
US6051258A
(en)
|
1995-06-07 |
2000-04-18 |
Emisphere Technologies, Inc. |
Proteinoid emulsions and methods for preparation and use thereof
|
US5750147A
(en)
|
1995-06-07 |
1998-05-12 |
Emisphere Technologies, Inc. |
Method of solubilizing and encapsulating itraconazole
|
CN1069827C
(zh)
*
|
1995-06-09 |
2001-08-22 |
浙江大学 |
一种多肽蛋白质药物微球的制备方法
|
CA2195119C
(en)
|
1995-06-09 |
2001-09-11 |
Mark Chasin |
Formulations and methods for providing prolonged local anesthesia
|
US6265389B1
(en)
|
1995-08-31 |
2001-07-24 |
Alkermes Controlled Therapeutics, Inc. |
Microencapsulation and sustained release of oligonucleotides
|
EP0850051A2
(de)
*
|
1995-08-31 |
1998-07-01 |
Alkermes Controlled Therapeutics, Inc. |
Mittel zur verzögerten freisetzung eines wirkstoffs
|
DE19681560T1
(de)
|
1995-09-11 |
1998-08-20 |
Emisphere Tech Inc |
Verfahren zur Herstellung von omega-Aminoalkansäure-Derivaten aus Cycloalkanonen
|
JP2909418B2
(ja)
*
|
1995-09-18 |
1999-06-23 |
株式会社資生堂 |
薬物の遅延放出型マイクロスフイア
|
US5665428A
(en)
*
|
1995-10-25 |
1997-09-09 |
Macromed, Inc. |
Preparation of peptide containing biodegradable microspheres by melt process
|
US5702717A
(en)
*
|
1995-10-25 |
1997-12-30 |
Macromed, Inc. |
Thermosensitive biodegradable polymers based on poly(ether-ester)block copolymers
|
JP2000500744A
(ja)
|
1995-11-09 |
2000-01-25 |
マイクロバイオロジカル リサーチ オーソリティー |
ワクチン接種および遺伝子治療のためのマイクロカプセル化dna
|
US6270795B1
(en)
|
1995-11-09 |
2001-08-07 |
Microbiological Research Authority |
Method of making microencapsulated DNA for vaccination and gene therapy
|
DE19545257A1
(de)
|
1995-11-24 |
1997-06-19 |
Schering Ag |
Verfahren zur Herstellung von morphologisch einheitlichen Mikrokapseln sowie nach diesem Verfahren hergestellte Mikrokapseln
|
US5723508A
(en)
*
|
1996-01-25 |
1998-03-03 |
Northwestern University |
Method of fabricating emulsion freeze-dried scaffold bodies and resulting products
|
AU2595697A
(en)
*
|
1996-03-29 |
1997-10-22 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
US5874064A
(en)
|
1996-05-24 |
1999-02-23 |
Massachusetts Institute Of Technology |
Aerodynamically light particles for pulmonary drug delivery
|
US5985309A
(en)
*
|
1996-05-24 |
1999-11-16 |
Massachusetts Institute Of Technology |
Preparation of particles for inhalation
|
US6652837B1
(en)
|
1996-05-24 |
2003-11-25 |
Massachusetts Institute Of Technology |
Preparation of novel particles for inhalation
|
US20020052310A1
(en)
*
|
1997-09-15 |
2002-05-02 |
Massachusetts Institute Of Technology The Penn State Research Foundation |
Particles for inhalation having sustained release properties
|
JP2000512671A
(ja)
|
1996-06-14 |
2000-09-26 |
エミスフェアー テクノロジーズ インク |
マイクロカプセル化香料及び調製方法
|
WO1997049391A1
(en)
|
1996-06-24 |
1997-12-31 |
Euro-Celtique, S.A. |
Methods for providing safe local anesthesia
|
WO1998001117A1
(en)
*
|
1996-07-08 |
1998-01-15 |
Edward Mendell Co., Inc. |
Sustained release matrix for high-dose insoluble drugs
|
US6046187A
(en)
|
1996-09-16 |
2000-04-04 |
Children's Medical Center Corporation |
Formulations and methods for providing prolonged local anesthesia
|
ATE272394T1
(de)
*
|
1996-10-31 |
2004-08-15 |
Takeda Chemical Industries Ltd |
Zubereitung mit verzögerter freisetzung
|
US20020182258A1
(en)
*
|
1997-01-22 |
2002-12-05 |
Zycos Inc., A Delaware Corporation |
Microparticles for delivery of nucleic acid
|
US5990166A
(en)
|
1997-02-07 |
1999-11-23 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
US6060513A
(en)
|
1997-02-07 |
2000-05-09 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
US6313088B1
(en)
|
1997-02-07 |
2001-11-06 |
Emisphere Technologies, Inc. |
8-[(2-hydroxy-4-methoxy benzoyl) amino]-octanoic acid compositions for delivering active agents
|
US5939381A
(en)
|
1997-02-07 |
1999-08-17 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
US5876710A
(en)
|
1997-02-07 |
1999-03-02 |
Emisphere Technologies Inc. |
Compounds and compositions for delivering active agents
|
US6126919A
(en)
|
1997-02-07 |
2000-10-03 |
3M Innovative Properties Company |
Biocompatible compounds for pharmaceutical drug delivery systems
|
US5879681A
(en)
|
1997-02-07 |
1999-03-09 |
Emisphere Technolgies Inc. |
Compounds and compositions for delivering active agents
|
US5804688A
(en)
|
1997-02-07 |
1998-09-08 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
US6358504B1
(en)
*
|
1997-02-07 |
2002-03-19 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
US5863944A
(en)
|
1997-04-30 |
1999-01-26 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
US5962710A
(en)
|
1997-05-09 |
1999-10-05 |
Emisphere Technologies, Inc. |
Method of preparing salicyloylamino acids
|
FR2764514B1
(fr)
|
1997-06-13 |
1999-09-03 |
Biopharmex Holding Sa |
Implant injectable en sous-cutane ou intradermique a bioresorbabilite controlee pour la chirurgie reparatrice ou plastique et la dermatologie esthetique
|
ATE261721T1
(de)
*
|
1997-06-13 |
2004-04-15 |
Nanopharm Ag |
System zur gezielten wirkstoffzufuhr, verfahren zu seiner herstellung und verwendung
|
AU751267B2
(en)
|
1997-06-30 |
2002-08-08 |
Monsanto Technology Llc |
Microparticles containing agricultural active ingredients
|
BR9815499A
(pt)
|
1997-07-02 |
2001-01-02 |
Euro Celtique Sa |
Anestesia prolongada nas juntas e nos espacos corporais.
|
WO1999008528A1
(en)
|
1997-08-19 |
1999-02-25 |
Emory University |
Noscapine derivatives, useful as anticancer agents
|
US6673814B2
(en)
*
|
1997-08-19 |
2004-01-06 |
Emory University |
Delivery systems and methods for noscapine and noscapine derivatives, useful as anticancer agents
|
US7052678B2
(en)
|
1997-09-15 |
2006-05-30 |
Massachusetts Institute Of Technology |
Particles for inhalation having sustained release properties
|
US6004573A
(en)
*
|
1997-10-03 |
1999-12-21 |
Macromed, Inc. |
Biodegradable low molecular weight triblock poly(lactide-co-glycolide) polyethylene glycol copolymers having reverse thermal gelation properties
|
US6117949A
(en)
*
|
1998-10-01 |
2000-09-12 |
Macromed, Inc. |
Biodegradable low molecular weight triblock poly (lactide-co-glycolide) polyethylene glycol copolymers having reverse thermal gelation properties
|
US6201072B1
(en)
|
1997-10-03 |
2001-03-13 |
Macromed, Inc. |
Biodegradable low molecular weight triblock poly(lactide-co- glycolide) polyethylene glycol copolymers having reverse thermal gelation properties
|
US6056977A
(en)
|
1997-10-15 |
2000-05-02 |
Edward Mendell Co., Inc. |
Once-a-day controlled release sulfonylurea formulation
|
KR19990065921A
(ko)
*
|
1998-01-19 |
1999-08-16 |
김충섭 |
항생제의서방성제제
|
KR100289471B1
(ko)
*
|
1998-01-19 |
2001-09-17 |
김충섭 |
휀타닐계마취제의이식형서방성제제
|
US6099859A
(en)
*
|
1998-03-20 |
2000-08-08 |
Andrx Pharmaceuticals, Inc. |
Controlled release oral tablet having a unitary core
|
US6406719B1
(en)
|
1998-05-13 |
2002-06-18 |
Microbiological Research Authority |
Encapsulation of bioactive agents
|
GB9810236D0
(en)
|
1998-05-13 |
1998-07-08 |
Microbiological Res Authority |
Improvements relating to encapsulation of bioactive agents
|
US6264991B1
(en)
|
1998-08-18 |
2001-07-24 |
Southern Research Institute |
Compositions and methods for treating intracellular infections
|
US6956021B1
(en)
|
1998-08-25 |
2005-10-18 |
Advanced Inhalation Research, Inc. |
Stable spray-dried protein formulations
|
US20050147690A1
(en)
*
|
1998-09-25 |
2005-07-07 |
Masters David B. |
Biocompatible protein particles, particle devices and methods thereof
|
US7662409B2
(en)
*
|
1998-09-25 |
2010-02-16 |
Gel-Del Technologies, Inc. |
Protein matrix materials, devices and methods of making and using thereof
|
US6143314A
(en)
*
|
1998-10-28 |
2000-11-07 |
Atrix Laboratories, Inc. |
Controlled release liquid delivery compositions with low initial drug burst
|
US6365173B1
(en)
|
1999-01-14 |
2002-04-02 |
Efrat Biopolymers Ltd. |
Stereocomplex polymeric carriers for drug delivery
|
US6306425B1
(en)
|
1999-04-09 |
2001-10-23 |
Southern Research Institute |
Injectable naltrexone microsphere compositions and their use in reducing consumption of heroin and alcohol
|
US6287588B1
(en)
*
|
1999-04-29 |
2001-09-11 |
Macromed, Inc. |
Agent delivering system comprised of microparticle and biodegradable gel with an improved releasing profile and methods of use thereof
|
US6277401B1
(en)
*
|
1999-05-07 |
2001-08-21 |
U.S. Dermatologics, Inc. |
Drug delivery device
|
US6444223B1
(en)
*
|
1999-05-28 |
2002-09-03 |
Alkermes Controlled Therapeutics, Inc. |
Method of producing submicron particles of a labile agent and use thereof
|
KR20010002589A
(ko)
*
|
1999-06-16 |
2001-01-15 |
김윤 |
생리활성물질 함유 생분해성 고분자 마이크로스피어의 제조방법
|
US7678364B2
(en)
|
1999-08-25 |
2010-03-16 |
Alkermes, Inc. |
Particles for inhalation having sustained release properties
|
WO2001013891A2
(en)
*
|
1999-08-25 |
2001-03-01 |
Advanced Inhalation Research, Inc. |
Modulation of release from dry powder formulations
|
US6749835B1
(en)
|
1999-08-25 |
2004-06-15 |
Advanced Inhalation Research, Inc. |
Formulation for spray-drying large porous particles
|
US20010036481A1
(en)
*
|
1999-08-25 |
2001-11-01 |
Advanced Inhalation Research, Inc. |
Modulation of release from dry powder formulations
|
FR2797784B1
(fr)
*
|
1999-08-27 |
2001-11-30 |
Mainelab |
Procede d'encapsulation de matieres actives par coacervation de polymeres en solvant organique non-chlore
|
AU762291B2
(en)
*
|
1999-09-30 |
2003-06-19 |
Penwest Pharmaceutical Co. |
Sustained release matrix systems for highly soluble drugs
|
US20050037086A1
(en)
*
|
1999-11-19 |
2005-02-17 |
Zycos Inc., A Delaware Corporation |
Continuous-flow method for preparing microparticles
|
US6465425B1
(en)
|
2000-02-10 |
2002-10-15 |
Alkermes Controlled Therapeutics, Inc. |
Microencapsulation and sustained release of biologically active acid-stable or free sulfhydryl-containing proteins
|
US6589549B2
(en)
|
2000-04-27 |
2003-07-08 |
Macromed, Incorporated |
Bioactive agent delivering system comprised of microparticles within a biodegradable to improve release profiles
|
US7018645B1
(en)
*
|
2000-04-27 |
2006-03-28 |
Macromed, Inc. |
Mixtures of various triblock polyester polyethylene glycol copolymers having improved gel properties
|
EP1292285A4
(de)
*
|
2000-06-02 |
2009-07-22 |
Eisai Corp North America |
Darreichungssystem für bioaktive stoffe
|
AU2001280165A1
(en)
*
|
2000-08-24 |
2002-03-04 |
Santen Pharmaceutical Co. Ltd. |
Drug-release controlling system
|
SE517422C2
(sv)
|
2000-10-06 |
2002-06-04 |
Bioglan Ab |
Farmaceutiskt acceptabel stärkelse
|
AU2001294459A1
(en)
|
2000-10-06 |
2002-04-15 |
Jagotec Ag |
A controlled-release, parenterally administrable microparticle preparation
|
SE517421C2
(sv)
|
2000-10-06 |
2002-06-04 |
Bioglan Ab |
Mikropartiklar, lämpade för parenteral administration, väsentligen bestående av stärkelse med minst 85 % amylopektin och med reducerad molekylvikt, samt framställning därav
|
US6866866B1
(en)
*
|
2000-11-03 |
2005-03-15 |
Andrx Labs, Llc |
Controlled release metformin compositions
|
SE518007C2
(sv)
|
2000-11-16 |
2002-08-13 |
Bioglan Ab |
Förfarande för framställning av mikropartiklar
|
US6767637B2
(en)
*
|
2000-12-13 |
2004-07-27 |
Purdue Research Foundation |
Microencapsulation using ultrasonic atomizers
|
US6599627B2
(en)
|
2000-12-13 |
2003-07-29 |
Purdue Research Foundation |
Microencapsulation of drugs by solvent exchange
|
ATE361057T1
(de)
|
2000-12-21 |
2007-05-15 |
Alrise Biosystems Gmbh |
Verfahren umfassend einen induzierten phasenübergang zur herstellung von hydrophobe wirkstoffe enthaltenden mikropartikeln
|
US20030125236A1
(en)
*
|
2000-12-29 |
2003-07-03 |
Advenced Inhalation Research, Inc. |
Particles for inhalation having rapid release properties
|
US20020141946A1
(en)
*
|
2000-12-29 |
2002-10-03 |
Advanced Inhalation Research, Inc. |
Particles for inhalation having rapid release properties
|
AU2002230993B2
(en)
*
|
2000-12-29 |
2006-02-02 |
Alkermes, Inc. |
Particles for inhalation having sustained release properties
|
JP2004521111A
(ja)
*
|
2001-01-25 |
2004-07-15 |
ユーロ−セルティーク,エス.エイ. |
局所麻酔薬および使用法
|
EP1408876A4
(de)
|
2001-06-22 |
2004-09-22 |
Durect Corp |
Koaxiale implantate nullter ordnung mit verlängerter freisetzung
|
US6703045B2
(en)
|
2001-08-21 |
2004-03-09 |
Council Of Scientific & Industrial Research |
Composition and method for maintaining blood glucose level
|
US7105181B2
(en)
|
2001-10-05 |
2006-09-12 |
Jagotec, Ag |
Microparticles
|
US8778322B2
(en)
*
|
2001-10-18 |
2014-07-15 |
Samyang Biopharmaceuticals Corporation |
pH responsive biodegradable polylactic acid derivatives forming polymeric micelles and uses thereof for poorly water soluble drug delivery
|
WO2003043603A1
(en)
*
|
2001-11-20 |
2003-05-30 |
Advanced Inhalation Research, Inc. |
Particulate compositions for improving solubility of poorly soluble agents
|
CA2465675C
(en)
|
2001-11-20 |
2008-06-10 |
Advanced Inhalation Research, Inc. |
Improved particulate compositions for pulmonary delivery
|
FR2832312B1
(fr)
*
|
2001-11-21 |
2004-01-16 |
Inst Nat Sante Rech Med |
Procede de preparation de microparticules sans solvant toxique, microparticules obtenues selon ce procede, utilisations et compositions pharmaceutiques
|
HK1077740A1
(en)
|
2001-12-20 |
2006-02-24 |
Ct Ingenieria Genetica Biotech |
Use of epidermal growth factor in the manufacture of a pharmaceutical injection composition for preventing diabetic limb amputation
|
AU2003225895A1
(en)
*
|
2002-03-19 |
2003-10-08 |
Purdue Research Foundation |
Microencapsulation using ultrasonic atomizers
|
SE0201599D0
(sv)
|
2002-03-21 |
2002-05-30 |
Skyepharma Ab |
Microparticles
|
US6890950B2
(en)
*
|
2002-04-23 |
2005-05-10 |
Case Western Reserve University |
Lapachone delivery systems, compositions and uses related thereto
|
WO2003092468A2
(en)
*
|
2002-04-29 |
2003-11-13 |
Gel-Del Technologies, Inc. |
Biomatrix structural containment and fixation systems and methods of use thereof
|
US20040052848A1
(en)
*
|
2002-05-23 |
2004-03-18 |
Xiu-Xiu Cheng |
Biguanide formulations
|
US7157102B1
(en)
*
|
2002-05-31 |
2007-01-02 |
Biotek, Inc. |
Multi-layered microcapsules and method of preparing same
|
US7649023B2
(en)
*
|
2002-06-11 |
2010-01-19 |
Novartis Ag |
Biodegradable block copolymeric compositions for drug delivery
|
US20030228366A1
(en)
*
|
2002-06-11 |
2003-12-11 |
Chung Shih |
Reconstitutable compositions of biodegradable block copolymers
|
WO2003105809A1
(en)
*
|
2002-06-17 |
2003-12-24 |
Themis Laboratories Private Limited |
Multilayer tablets containing thiazolidinedione and biguanides and methods for producing them
|
JP4530626B2
(ja)
*
|
2002-06-25 |
2010-08-25 |
武田薬品工業株式会社 |
徐放性組成物の製造方法
|
DK1532985T3
(en)
|
2002-06-25 |
2016-12-05 |
Takeda Pharmaceuticals Co |
PROCEDURE FOR PREPARING A COMPOSITION WITH LONG-TERM RELEASE
|
GB2399084B
(en)
*
|
2002-07-30 |
2007-01-31 |
Univ Liverpool |
Porous beads and method of production thereof
|
EP2277551B1
(de)
|
2002-09-06 |
2013-05-08 |
Cerulean Pharma Inc. |
Polymere auf basis von cyclodextrin zur verabreichung von an diese kovalent gebundene arzneimittel
|
CN100339070C
(zh)
|
2002-10-24 |
2007-09-26 |
莫茨药物股份两合公司 |
包含1-氨基环己烷衍生物类和乙酰胆碱酯酶抑制剂类的药物组合物
|
WO2004049801A1
(ja)
*
|
2002-12-04 |
2004-06-17 |
Nippon Soda Co., Ltd. |
Oil/Oil液中乾燥法による農薬マイクロカプセル製剤及びその製造方法
|
MXPA05012493A
(es)
*
|
2003-05-27 |
2006-05-25 |
Forest Laboratories |
Combinacion de un antagonista del receptor de nmda y un inhibidor selectivo de reabsorcion de serotonina para el tratamiento de depresion y otros trastornos de estado de animo.
|
US8465537B2
(en)
*
|
2003-06-17 |
2013-06-18 |
Gel-Del Technologies, Inc. |
Encapsulated or coated stent systems
|
CA2537315C
(en)
|
2003-08-26 |
2015-12-08 |
Gel-Del Technologies, Inc. |
Protein biomaterials and biocoacervates and methods of making and using thereof
|
US7311901B2
(en)
|
2003-10-10 |
2007-12-25 |
Samyang Corporation |
Amphiphilic block copolymer and polymeric composition comprising the same for drug delivery
|
EP1682109B1
(de)
*
|
2003-10-22 |
2008-10-15 |
Merz Pharma GmbH & Co. KGaA |
Verwendung von 1-aminocyclohexan-derivaten zur modifizierung der abscheidung von fibrillogenen as peptiden in amyloidpathien
|
CA2548822C
(en)
*
|
2003-12-08 |
2015-08-11 |
Gel-Del Technologies, Inc. |
Mucoadhesive drug delivery devices and methods of making and using thereof
|
JP4961213B2
(ja)
*
|
2004-01-21 |
2012-06-27 |
ザ・スクール・オブ・ファーマシー |
マイクロ粒子の製造方法
|
DK2074989T3
(da)
*
|
2004-02-23 |
2014-02-03 |
Euro Celtique Sa |
Misbrugssikker transdermal opioid-afgivelsesanordning
|
WO2005110369A2
(en)
*
|
2004-04-30 |
2005-11-24 |
American Pharmaceutical Partners, Inc. |
Sustained-release microspheres and methods of making and using same
|
TW200616608A
(en)
*
|
2004-07-09 |
2006-06-01 |
Forest Laboratories |
Memantine as adjunctive treatment to atypical antipsychotics in schizophrenia patients
|
AU2005272578A1
(en)
*
|
2004-08-13 |
2006-02-23 |
Angiotech International Ag |
Compositions and methods using hyaluronic acid and hyluronidase inhibitors
|
US20060079582A1
(en)
*
|
2004-09-23 |
2006-04-13 |
Jeffrey Jonas |
Memantine for the treatment of childhood behavioral disorders
|
CN100349612C
(zh)
*
|
2005-02-05 |
2007-11-21 |
复旦大学 |
含葡激酶突变体的缓释微球制剂及其制备方法
|
CN101437539B
(zh)
*
|
2005-07-05 |
2013-10-02 |
康奈尔研究基金会(有限公司) |
通过干扰cd99l2阻断白细胞迁出和炎症
|
US20070031611A1
(en)
*
|
2005-08-04 |
2007-02-08 |
Babaev Eilaz P |
Ultrasound medical stent coating method and device
|
US9101949B2
(en)
*
|
2005-08-04 |
2015-08-11 |
Eilaz Babaev |
Ultrasonic atomization and/or seperation system
|
US7896539B2
(en)
*
|
2005-08-16 |
2011-03-01 |
Bacoustics, Llc |
Ultrasound apparatus and methods for mixing liquids and coating stents
|
JP5554496B2
(ja)
*
|
2005-09-19 |
2014-07-23 |
ニューロナセント インコーポレイテッド |
神経発生を刺激するための、およびニューロン変性を阻害するための方法および組成物
|
US7942867B2
(en)
*
|
2005-11-09 |
2011-05-17 |
The Invention Science Fund I, Llc |
Remotely controlled substance delivery device
|
CU23388B6
(es)
*
|
2006-01-31 |
2009-07-16 |
Ct Ingenieria Genetica Biotech |
Composición farmacéutica de microesferas para prevenir la amputación del pie diabético
|
CU23558A1
(es)
|
2006-02-28 |
2010-07-20 |
Ct Ingenieria Genetica Biotech |
Compuestos análogos a los secretagogos peptidicos de la hormona de crecimiento
|
US9289196B2
(en)
|
2006-12-12 |
2016-03-22 |
Cook Medical Technologies Llc |
Hemostatic substance with a coating
|
US20080142616A1
(en)
*
|
2006-12-15 |
2008-06-19 |
Bacoustics Llc |
Method of Producing a Directed Spray
|
WO2008091871A2
(en)
*
|
2007-01-22 |
2008-07-31 |
Archer-Daniels-Midland Company |
Water dispersible compositions comprising a naturally occurring nematicide, lecithin, and a co-surfactant
|
JP2010516625A
(ja)
|
2007-01-24 |
2010-05-20 |
インサート セラピューティクス, インコーポレイテッド |
制御された薬物送達のためのテザー基を有するポリマー−薬物コンジュゲート
|
US7960139B2
(en)
|
2007-03-23 |
2011-06-14 |
Academia Sinica |
Alkynyl sugar analogs for the labeling and visualization of glycoconjugates in cells
|
AU2008265600B2
(en)
|
2007-06-21 |
2013-10-31 |
Neuronascent, Inc. |
Methods and compositions for stimulating neurogenesis and inhibiting neuronal degeneration using isothiazolopyrimidinones
|
US7753285B2
(en)
|
2007-07-13 |
2010-07-13 |
Bacoustics, Llc |
Echoing ultrasound atomization and/or mixing system
|
US7780095B2
(en)
|
2007-07-13 |
2010-08-24 |
Bacoustics, Llc |
Ultrasound pumping apparatus
|
EP2548552B1
(de)
|
2007-09-12 |
2015-11-18 |
Merz Pharma GmbH & Co. KGaA |
Titrationspaket für 1-Amino-Alkylcyclohexane
|
AU2008345047A1
(en)
*
|
2007-12-26 |
2009-07-09 |
Gel-Del Technologies, Inc. |
Biocompatible protein particles, particle devices and methods thereof
|
EP2085120A1
(de)
|
2008-02-01 |
2009-08-05 |
Merz Pharma GmbH & Co. KGaA |
Verwendung von Substanzen zur Behandlung zentraler und peripherer Insulinrezeptorbeeinträchtigung oder Insulinresistenz
|
US20090202642A1
(en)
*
|
2008-02-08 |
2009-08-13 |
Xiao Huang |
Drug Delivery System Comprising Microparticles and Gelation System
|
US8680020B2
(en)
|
2008-07-15 |
2014-03-25 |
Academia Sinica |
Glycan arrays on PTFE-like aluminum coated glass slides and related methods
|
JP5713897B2
(ja)
*
|
2008-07-16 |
2015-05-07 |
エボニック コーポレイションEvonik Corporation |
生理活性ペプチドを含有する微粒子を調製するためのプロセス
|
WO2010057177A2
(en)
|
2008-11-17 |
2010-05-20 |
Gel-Del Technologies, Inc. |
Protein biomaterial and biocoacervate vessel graft systems and methods of making and using thereof
|
TWI432188B
(zh)
|
2008-12-19 |
2014-04-01 |
Merz Pharma Gmbh & Co Kgaa |
供治療發炎性皮膚疾病之1-胺基-烷基環己烷衍生物類
|
CN102159201A
(zh)
|
2008-12-19 |
2011-08-17 |
莫茨药物股份两合公司 |
用于治疗肥大细胞介导的疾病的1-氨基-烷基环己烷衍生物
|
KR101105292B1
(ko)
|
2009-06-05 |
2012-01-17 |
주식회사 리젠 바이오텍 |
생분해성 고분자 미세입자와 그의 제조방법
|
US20120190690A1
(en)
|
2009-06-30 |
2012-07-26 |
Merz Pharma Gmbh & Co. Kgaa |
Eltoprazine for the treatment of weight disorders
|
WO2011000562A1
(en)
|
2009-06-30 |
2011-01-06 |
Merz Pharma Gmbh & Co. Kgaa |
Eltoprazine for the treatment of certain movement disorders
|
WO2011000564A1
(en)
|
2009-06-30 |
2011-01-06 |
Merz Pharma Gmbh & Co. Kgaa |
Eltoprazine for the treatment of drug addiction
|
EP2448580A1
(de)
|
2009-06-30 |
2012-05-09 |
Merz Pharma GmbH & Co. KGaA |
Eltoprazin zur behandlung von angstzuständen
|
EA201200486A1
(ru)
|
2009-09-15 |
2012-08-30 |
Серулин Фарма Инк. |
Лечение онкологических заболеваний
|
CN101693177B
(zh)
*
|
2009-10-19 |
2012-07-04 |
上海现代药物制剂工程研究中心有限公司 |
基于超声技术的微球制备方法及其装置
|
CN102781237A
(zh)
*
|
2009-11-23 |
2012-11-14 |
天蓝制药公司 |
用于传递治疗剂的基于环糊精的聚合物
|
US11377485B2
(en)
|
2009-12-02 |
2022-07-05 |
Academia Sinica |
Methods for modifying human antibodies by glycan engineering
|
US10087236B2
(en)
|
2009-12-02 |
2018-10-02 |
Academia Sinica |
Methods for modifying human antibodies by glycan engineering
|
WO2011130332A1
(en)
|
2010-04-12 |
2011-10-20 |
Academia Sinica |
Glycan arrays for high throughput screening of viruses
|
EP2571525A4
(de)
|
2010-05-18 |
2016-04-27 |
Cerulean Pharma Inc |
Zusammensetzungen und verfahren zur behandlung von autoimmun- und anderen erkrankungen
|
US20110294890A1
(en)
|
2010-05-28 |
2011-12-01 |
Merz Pharma Gmbh & Co. Kgaa |
Neramexane for the treatment or prevention of inner ear disorders
|
KR20120011344A
(ko)
*
|
2010-07-21 |
2012-02-08 |
에스케이케미칼주식회사 |
고분자 미립구의 제조방법 및 그 방법에 의해 제조된 고분자 미립구
|
WO2012023033A2
(en)
|
2010-08-18 |
2012-02-23 |
Purdue Pharma L.P. |
Improved peptide immunogens
|
WO2012098000A1
(en)
|
2011-01-20 |
2012-07-26 |
Merz Pharma Gmbh & Co. Kgaa |
Neramexane for the treatment or prevention of tinnitus related with stress or acute hearing loss
|
CN113018452A
(zh)
|
2011-04-29 |
2021-06-25 |
西莱克塔生物科技公司 |
用于效应性t细胞的抗原特异性缺失的致耐受性合成纳米载体
|
WO2012171653A1
(en)
|
2011-06-15 |
2012-12-20 |
Merz Pharma Gmbh & Co. Kgaa |
Sarizotan for use in the treatment of attention deficit hyperactivity disorder (adhd)
|
US10130714B2
(en)
|
2012-04-14 |
2018-11-20 |
Academia Sinica |
Enhanced anti-influenza agents conjugated with anti-inflammatory activity
|
TW201412325A
(zh)
|
2012-06-20 |
2014-04-01 |
梅茲製藥有限兩合公司 |
用於治療患有青光眼及其他退化性眼疾之人類視力喪失的間隔醫療
|
JP6302909B2
(ja)
|
2012-08-18 |
2018-03-28 |
アカデミア シニカAcademia Sinica |
シアリダーゼの同定および画像化のための細胞透過性プローブ
|
US20140094432A1
(en)
|
2012-10-02 |
2014-04-03 |
Cerulean Pharma Inc. |
Methods and systems for polymer precipitation and generation of particles
|
KR101481441B1
(ko)
|
2013-02-22 |
2015-01-13 |
주식회사 바임 |
폴리락트산(pla) 미세입자의 스프레이 공법에 따른 제조방법
|
CA2910575C
(en)
|
2013-05-03 |
2023-10-24 |
Selecta Biosciences, Inc. |
Tolerogenic synthetic nanocarriers and therapeutic macromolecules for reduced or enhanced pharmacodynamic effects
|
WO2014210397A1
(en)
|
2013-06-26 |
2014-12-31 |
Academia Sinica |
Rm2 antigens and use thereof
|
US9981030B2
(en)
|
2013-06-27 |
2018-05-29 |
Academia Sinica |
Glycan conjugates and use thereof
|
CN105682666B
(zh)
|
2013-09-06 |
2021-06-01 |
中央研究院 |
使用醣脂激活人类iNKT细胞
|
JP6463366B2
(ja)
|
2013-10-10 |
2019-01-30 |
イースタン バージニア メディカル スクール |
12−リポキシゲナーゼ阻害物質としての4−((2−ヒドロキシ−3−メトキシベンジル)アミノ)ベンゼンスルホンアミド誘導体
|
EP3094352B1
(de)
|
2014-01-16 |
2020-09-23 |
Academia Sinica |
Zusammensetzungen und verfahren zur behandlung und zum nachweis von krebs
|
US10150818B2
(en)
|
2014-01-16 |
2018-12-11 |
Academia Sinica |
Compositions and methods for treatment and detection of cancers
|
EP3129767B1
(de)
|
2014-03-27 |
2021-09-01 |
Academia Sinica |
Reaktive markierungsverbindungen und ihre verwendungen
|
TWI717319B
(zh)
|
2014-05-27 |
2021-02-01 |
中央研究院 |
得自類桿菌屬之岩藻糖苷酶及其用途
|
TWI679020B
(zh)
|
2014-05-27 |
2019-12-11 |
中央研究院 |
抗her2醣抗體及其用途
|
KR20170003720A
(ko)
|
2014-05-27 |
2017-01-09 |
아카데미아 시니카 |
항-cd20 글리코항체 및 이의 용도
|
US10118969B2
(en)
|
2014-05-27 |
2018-11-06 |
Academia Sinica |
Compositions and methods relating to universal glycoforms for enhanced antibody efficacy
|
KR102494193B1
(ko)
|
2014-05-28 |
2023-01-31 |
아카데미아 시니카 |
항-tnf-알파 글리코항체 및 이의 용도
|
IL292577A
(en)
|
2014-09-07 |
2022-06-01 |
Selecta Biosciences Inc |
Methods and preparations for attenuating immune responses of gene editing in an antiviral transfer system
|
CN107001404B
(zh)
|
2014-09-08 |
2021-06-29 |
中央研究院 |
使用醣脂激活人类iNKT细胞
|
US10495645B2
(en)
|
2015-01-16 |
2019-12-03 |
Academia Sinica |
Cancer markers and methods of use thereof
|
US9975965B2
(en)
|
2015-01-16 |
2018-05-22 |
Academia Sinica |
Compositions and methods for treatment and detection of cancers
|
JP6779887B2
(ja)
|
2015-01-24 |
2020-11-04 |
アカデミア シニカAcademia Sinica |
新規なグリカンコンジュゲートおよびその使用方法
|
EP3344806A4
(de)
|
2015-09-04 |
2019-03-20 |
OBI Pharma, Inc. |
Glycanarrays und verfahren zur verwendung
|
CA3016170A1
(en)
|
2016-03-08 |
2017-09-14 |
Academia Sinica |
Methods for modular synthesis of n-glycans and arrays thereof
|
US10980894B2
(en)
|
2016-03-29 |
2021-04-20 |
Obi Pharma, Inc. |
Antibodies, pharmaceutical compositions and methods
|
CA3019560A1
(en)
|
2016-03-29 |
2017-10-05 |
Obi Pharma, Inc. |
Antibodies, pharmaceutical compositions and methods
|
KR20230110820A
(ko)
|
2016-04-22 |
2023-07-25 |
오비아이 파머 인코퍼레이티드 |
글로보 계열 항원을 통한 면역 활성화 또는 면역 조정에의한 암 면역요법
|
CN105963257B
(zh)
*
|
2016-04-26 |
2021-01-22 |
广州帝奇医药技术有限公司 |
一种缓释微粒的制备方法
|
EP3490592A4
(de)
|
2016-07-27 |
2020-03-25 |
OBI Pharma, Inc. |
Immunogene/therapeutische glycanzusammensetzungen und verwendungen davon
|
WO2018023121A1
(en)
|
2016-07-29 |
2018-02-01 |
Obi Pharma, Inc. |
Human antibodies, pharmaceutical compositions and methods
|
JP7213549B2
(ja)
|
2016-08-22 |
2023-01-27 |
シーエイチオー ファーマ インコーポレイテッド |
抗体、結合性断片、および使用の方法
|
US20180071394A1
(en)
*
|
2016-08-25 |
2018-03-15 |
Selecta Biosciences, Inc. |
Polyester polymer matrices for the delivery of allergens
|
EP3541414A4
(de)
|
2016-11-21 |
2020-11-11 |
OBI Pharma, Inc. |
Konjugierte biologische moleküle, pharmazeutische zusammensetzungen und verfahren
|
BR112019018748A2
(pt)
|
2017-03-11 |
2020-04-07 |
Selecta Biosciences Inc |
métodos e composições relacionados ao tratamento combinado com anti-inflamatórios e nanocarreadores sintéticos compreendendo um imunossupressor
|
PE20210047A1
(es)
*
|
2018-06-12 |
2021-01-08 |
Farm Rovi Lab Sa |
Composicion inyectable
|
US11203645B2
(en)
|
2018-06-27 |
2021-12-21 |
Obi Pharma, Inc. |
Glycosynthase variants for glycoprotein engineering and methods of use
|
EP3791873A1
(de)
|
2019-09-16 |
2021-03-17 |
Universite De Bordeaux |
Verfahren zur behandlung und/oder vorbeugung von erkrankungen und symptomen im zusammenhang mit bkca- und/oder sk-kanalophathien
|
KR20210054660A
(ko)
*
|
2019-11-05 |
2021-05-14 |
주식회사 넥스트바이오메디컬 |
초기 방출 제어가 가능한 서방출성 미립구 및 이의 제조 방법
|
JP2023536346A
(ja)
|
2020-08-05 |
2023-08-24 |
エリプシーズ ファーマ リミテッド |
シクロデキストリン含有ポリマートポイソメラーゼ阻害剤コンジュゲートおよびparp阻害剤を用いた癌の処置
|
WO2023056368A1
(en)
|
2021-09-30 |
2023-04-06 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Cyclic peptides as non-hormonal male contraceptive agents and methods of use thereof
|
WO2023054704A1
(ja)
*
|
2021-09-30 |
2023-04-06 |
日産化学株式会社 |
水溶性化合物とレシチンからなる複合体油中分散液の製造方法
|
CN115634213A
(zh)
*
|
2022-10-17 |
2023-01-24 |
浙江理工大学湖州研究院有限公司 |
一种具有生理温度智能响应的复合载药微球的制备方法
|